Association of kidney and liver biomarkers with MetS
Madhavi Bhatia, National Institute of Pharmaceutical Education and Research, Guwahati Metabolic syndrome (MetS) is a group of cardiometabolic conditions that are leading contributors to an elevated risk for cardiovascular disease (CVD) and type II diabetes. Many consequences have been identified which occur due to MetS, an increased risk of fatty liver disease, renal disease, and […]